These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

513 related items for PubMed ID: 11108250

  • 1. Chronic blockade of the melanocortin 4 receptor subtype leads to obesity independently of neuropeptide Y action, with no adverse effects on the gonadotropic and somatotropic axes.
    Raposinho PD, Castillo E, d'Alleves V, Broqua P, Pralong FP, Aubert ML.
    Endocrinology; 2000 Dec; 141(12):4419-27. PubMed ID: 11108250
    [Abstract] [Full Text] [Related]

  • 2. The melanocortin agonist Melanotan-II reduces the orexigenic and adipogenic effects of neuropeptide Y (NPY) but does not affect the NPY-driven suppressive effects on the gonadotropic and somatotropic axes in the male rat.
    Raposinho PD, White RB, Aubert ML.
    J Neuroendocrinol; 2003 Feb; 15(2):173-81. PubMed ID: 12535159
    [Abstract] [Full Text] [Related]

  • 3. Hypothalamic, metabolic, and behavioral responses to pharmacological inhibition of CNS melanocortin signaling in rats.
    Adage T, Scheurink AJ, de Boer SF, de Vries K, Konsman JP, Kuipers F, Adan RA, Baskin DG, Schwartz MW, van Dijk G.
    J Neurosci; 2001 May 15; 21(10):3639-45. PubMed ID: 11331393
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pituitary adenylate cyclase-activating polypeptide inhibits food intake in mice through activation of the hypothalamic melanocortin system.
    Mounien L, Do Rego JC, Bizet P, Boutelet I, Gourcerol G, Fournier A, Brabet P, Costentin J, Vaudry H, Jégou S.
    Neuropsychopharmacology; 2009 Jan 15; 34(2):424-35. PubMed ID: 18536705
    [Abstract] [Full Text] [Related]

  • 12. Resistance to the satiety action of leptin following chronic central leptin infusion is associated with the development of leptin resistance in neuropeptide Y neurones.
    Sahu A.
    J Neuroendocrinol; 2002 Oct 15; 14(10):796-804. PubMed ID: 12372004
    [Abstract] [Full Text] [Related]

  • 13. Central proopiomelanocortin but not neuropeptide Y mediates sympathoexcitation and hypertension in fat fed conscious rabbits.
    Barzel B, Lim K, Davern PJ, Burke SL, Armitage JA, Head GA.
    J Hypertens; 2016 Mar 15; 34(3):464-73; discussion 473. PubMed ID: 26820476
    [Abstract] [Full Text] [Related]

  • 14. The melanocortin 4 receptor mediates leptin stimulation of luteinizing hormone and prolactin surges in steroid-primed ovariectomized rats.
    Watanobe H, Schiöth HB, Wikberg JE, Suda T.
    Biochem Biophys Res Commun; 1999 Apr 21; 257(3):860-4. PubMed ID: 10208874
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Daily changes in hypothalamic gene expression of neuropeptide Y, galanin, proopiomelanocortin, and adipocyte leptin gene expression and secretion: effects of food restriction.
    Xu B, Kalra PS, Farmerie WG, Kalra SP.
    Endocrinology; 1999 Jun 21; 140(6):2868-75. PubMed ID: 10342879
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.